Recursion Pharmaceuticals had a revenue of 19.10M in the quarter ending Jun 30, 2025, with 29.56%. This bring the company's revenue in the last twelve months to 64.44M, Decreased 7.84%. In the fiscal year ending Dec 31, 2024, Recursion Pharmaceuticals had annual revenue of 58.84M with 32.00% growth.